GCB Capital

GCB Capital Limited is the investment banking subsidiary of Ghana’s largest indigenous bank, GCB Bank PLC. It was originally incorporated as Development Finance & Holdings Ltd., then spun off and renamed as "GCB Securities Ltd" in November 2018 before adopting its current name in August 2020[2]. The firm offers fund management, financial advisory and capital market services, proprietary debt/equity investing, real estate finance solutions and long-term financing for public/private corporates and government agencies across Ghana[2]. It does not operate within the life sciences/biotech/pharma/healthcare sector—its focus is strictly on financial services and investment banking activities.

There are no indications that it develops therapeutics or medical technologies nor does it have any clinical pipeline or health-related platform technology. Its parent company is GCB Bank PLC—the largest universal bank in Ghana with a broad national footprint[1][5].

No evidence was found linking this entity to drug development or healthcare operations of any kind. If you are seeking information about a similarly named entity within biotech/pharma/life sciences/healthcare sectors elsewhere globally, there may be no direct match for “GCB Securities” fitting those criteria based on available data.